These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6714291)

  • 1. Acetylator phenotypes: effect of age.
    Gachályi B; Vas A; Hajós P; Káldor A
    Eur J Clin Pharmacol; 1984; 26(1):43-5. PubMed ID: 6714291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic discrimination of three sulfamethazine acetylation phenotypes.
    Chapron DJ; Kramer PA; Mercik SA
    Clin Pharmacol Ther; 1980 Jan; 27(1):104-13. PubMed ID: 7351110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic acetylator phenotype in diabetes mellitus.
    Ladero JM; Arrojo A; de Salamanca RE; Gomez M; Cano F; Alfonso M
    Ann Clin Res; 1982 Aug; 14(4):187-9. PubMed ID: 7168549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug acetylation and expression of lupus erythematosus.
    Marsden JR; Mason GG; Coburn PR; Rawlins MD; Shuster S
    Eur J Clin Pharmacol; 1985; 28(4):387-90. PubMed ID: 4029245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acetylator phenotype in spondylarthritis ankylopoietica].
    Rojkovich B; Genti G; Borbás E; Bálint G; Gömör B
    Orv Hetil; 1989 Dec; 130(49):2639-41. PubMed ID: 2689951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of acetylator phenotype in Sri Lankans.
    Perera PL; Weerasinghe WM
    Ceylon Med J; 1987 Mar; 32(1):29-34. PubMed ID: 3690726
    [No Abstract]   [Full Text] [Related]  

  • 7. N-acetylation and oxidative capacity in aged volunteers determined with sulfamethazine and antipyrine.
    Siegmund W; Franke G; Wulkow R; Hanke W; Thonack R
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):469-73. PubMed ID: 1813431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylation polymorphism and leprosy.
    Eze LC; Okpogba AN; Ogan AU
    Biochem Genet; 1990 Feb; 28(1-2):1-7. PubMed ID: 2344344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylator phenotypes in hyperthyroidism.
    Siegmund W; Franke G; Meng S; Gothe P; Meng W
    Int J Clin Pharmacol Ther Toxicol; 1988 Aug; 26(8):397-9. PubMed ID: 3220615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological evidence for N-acetyltransferase isozymes in the rabbit.
    Reeves PT; Kinnear BF; Minchin RF; Ilett KF
    Mol Pharmacol; 1991 Jan; 39(1):42-8. PubMed ID: 1987451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple test for acetylator phenotype using caffeine.
    Grant DM; Tang BK; Kalow W
    Br J Clin Pharmacol; 1984 Apr; 17(4):459-64. PubMed ID: 6721992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylation phenotyping with sulphadimidine in a Turkish population.
    Bozkurt A; Basci NE; Kalan S; Tuncer M; Kayaalp SO
    Eur J Clin Pharmacol; 1990; 38(1):53-6. PubMed ID: 2328748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should the acetylator phenotype be determined when prescribing hydralazine for hypertension?
    Ramsay LE; Silas JH; Ollerenshaw JD; Tucker GT; Phillips FC; Freestone S
    Eur J Clin Pharmacol; 1984; 26(1):39-42. PubMed ID: 6714290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Direct and indirect determination of an acetylator phenotype in patients during treatment with hydralazine].
    McNair A; Kristensen MB; Angelo HR; Christensen JM
    Ugeskr Laeger; 1981 Jun; 143(27):1696-9. PubMed ID: 7292741
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of concomitant isoniazid administration on determination of acetylator phenotype by sulphadimidine.
    Zysset T; Peretti E
    Eur J Clin Pharmacol; 1986; 30(4):463-6. PubMed ID: 3743623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylator genotype and arylamine-induced carcinogenesis.
    Hein DW
    Biochim Biophys Acta; 1988 Aug; 948(1):37-66. PubMed ID: 3293663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylator status and diabetic neuropathy.
    Shenfield GM; McCann VJ; Tjokresetio R
    Diabetologia; 1982 Jun; 22(6):441-4. PubMed ID: 7106444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Distribution of acetylator phenotypes in the normal Moscow city population and in chronic alcoholism].
    Lil'in ET; Korsunskaia MP; Meksin VA; Drozdov ES; Nazarov VV
    Genetika; 1984 Sep; 20(9):1557-9. PubMed ID: 6542045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic acetylator phenotype in bladder cancer patients.
    Ladero JM; Kwok CK; Jara C; Fernandez L; Silmi AM; Tapia D; Uson AC
    Ann Clin Res; 1985; 17(3):96-9. PubMed ID: 4051447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug acetylator phenotypes in newborn infants.
    Szórády I; Sánta A; Veress I
    Biol Res Pregnancy Perinatol; 1987; 8(1 1ST Half):23-5. PubMed ID: 3580445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.